In this video clip, Anderson discusses the technical barriers that are preventing full digital integration. Andrew Anderson ...

GLP-1 receptor agonists (GLP-1 RAs) are transforming metabolic disease treatment, with analytical chemists playing a critical role in formulation, stability testing, and clinical trial support for ...

In the first part of this roundtable discussion focused on the experiences, challenges, and contributions of women in chromatography, LCGC International spoke to Susanne Boye, Daniela Held, and ...

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Researchers investigating the prevalence of vitamin D deficiency and insufficiency in individuals with chronic spinal cord injury assessed participants’ vitamin D levels using high-performance liquid ...

The speakers highlight emerging trends in GLP-1 therapy, including personalized dosing, weight maintenance, combination ...

Leslie Wubbel, SaaS Product Manager at LabVantage, shares how the LabVantage cloud-based Laboratory Information Management ...

Judith Hey-Hadavi and Nicole Snow explore GLP-1 drug shortages, the safety and regulation of compounded alternatives, and ...

Diazonium chemistry offers a stable alternative for silica modification, creating a polymeric-like layer with enhanced hydrolytic stability.

Andrew Anderson, VP of innovation and informatics strategy at ACD/Labs, talks about how the scientific method is being redefined and the role the AI-digital-physical DMTA cycle plays.

Judith Hey-Hadavi and Nicole Snow discuss GLP-1 receptor agonists, emphasizing personalized dosing, side effect management, ...

IQ Consortium experts explain how advanced chromatographic and analytical strategies are improving the bioanalysis, ...